DataMEDS AI Amends LOI for Multi-Party Acquisitions; Ownership Shift
DataMEDS AI, Inc. (formerly Wellgistics Health, Inc.) entered into an Amended and Restated Letter of Intent (LOI) on July 29, 2026, outlining a complex multi-party transaction. The company plans to acquire or license intellectual property from EOS Technology Holdings and Scilex Holding Company, expand its license with Datavault AI Inc., and acquire a controlling interest in Tollo Health, LLC from HealthBridge Advisors, LLC. Post-closing, EOS, Scilex, Datavault, and HealthBridge Advisors are expected to collectively own approximately 84.6% of DataMEDS AI's common stock, with existing public shareholders holding about 10.4%. The transaction is subject to numerous conditions, including definitive agreements, financing, and regulatory approvals, with no assurance of completion.
Key Highlights
- Amended and Restated Letter of Intent (LOI) signed July 29, 2026, superseding May 18, 2026 term sheet.
- DataMEDS AI to acquire Quality of Life Peace of Mind (QOLPOM) IP from EOS Technology Holdings and Scilex Holding Company.
- Expand PharmacyChain license with Datavault AI Inc. to exclusively include Datavault AI Health.
- Acquire controlling interest in Tollo Health, LLC from HealthBridge Advisors, LLC (HBA).
- EOS, Scilex, Datavault, and HBA are expected to collectively own approximately 84.6% of common stock post-closing.
- Existing public common stockholders are expected to hold the remaining approximately 10.4% post-closing.
- Transaction is subject to due diligence, definitive agreements, financing, and regulatory approvals.
- Contemplates immediate appointment of new Interim Co-CEO and Interim VP of Finance.
Price Impact
More from WGRX